Cargando…
Hexokinase 2 confers radio-resistance in hepatocellular carcinoma by promoting autophagy-dependent degradation of AIMP2
With technological advancements, radiotherapy (RT) has become an effective non-surgical treatment for hepatocellular carcinoma (HCC), comprehensively improving the local control rate of patients with HCC. However, some patients with HCC still experience radio-resistance, cancer recurrence, and dista...
Autores principales: | Zheng, Yilin, Zhan, Yizhi, Zhang, Yuqin, Zhang, Yaowei, Liu, Yang, Xie, Yuwen, Sun, Yining, Qian, Junying, Ding, Yanqing, Ding, Yi, Fang, Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390495/ https://www.ncbi.nlm.nih.gov/pubmed/37524692 http://dx.doi.org/10.1038/s41419-023-06009-2 |
Ejemplares similares
-
VPS35 regulates parkin substrate AIMP2 toxicity by facilitating lysosomal clearance of AIMP2
por: Yun, Seung Pil, et al.
Publicado: (2017) -
Anticancer Activity of Pyrimethamine via Ubiquitin Mediated Degradation of AIMP2-DX2
por: Kim, Dae Gyu, et al.
Publicado: (2020) -
Targeting hexokinase 2 enhances response to radio-chemotherapy in glioblastoma
por: Vartanian, Alenoush, et al.
Publicado: (2016) -
AIMP2-DX2 Promotes the Proliferation, Migration, and Invasion of Nasopharyngeal Carcinoma Cells
por: Cao, Qingsong, et al.
Publicado: (2018) -
AIMP3 inhibits cell growth and metastasis of lung adenocarcinoma through activating a miR‐96‐5p‐AIMP3‐p53 axis
por: Ding, Liting, et al.
Publicado: (2021)